Tudor Investment Corp’s CareMax, Inc. Class A Common Stock CMAX Stock Holding History

Tudor Investment Corp’s Portfolio CMAX Stock Details CMAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-414	Closed	-$33K	–	3097
2023 Q1	$33K	Buy	+414	New	+$48.4K	﹤0.01%	2300

Other funds holding CMAX

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Tudor Investment Corp's CMAX Position: Q2 2023 in Review

Tudor Investment Corp sold out of CareMax, Inc. Class A Common Stock (CMAX) in Q2 2023, closing a stake of 414 shares — an estimated $33K sold.

Tudor Investment Corp first reported a position in CMAX in Q1 2023 and held it in 1 quarter. The position peaked at $33K in Q1 2023. 72 funds tracked by Wall St. Rank hold CMAX as of Q2 2023.

Tudor Investment Corp reported no remaining CareMax, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Tudor Investment Corp sold 414 CareMax, Inc. Class A Common Stock shares in Q2 2023, an estimated $33K.
Tudor Investment Corp first reported a position in CareMax, Inc. Class A Common Stock in Q1 2023 and held it in 1 quarter.
Tudor Investment Corp's CareMax, Inc. Class A Common Stock position peaked at $33K in Q1 2023.
72 funds tracked by Wall St. Rank held CareMax, Inc. Class A Common Stock as of Q2 2023.

Based on Tudor Investment Corp's 13F filing for Q2 2023, filed 14 Aug 2023.